Update on the Management of Vitiligo

Nahhas, A.F.; Braunberger, T.L.; Hamzavi, I.H.

Skin Therapy Letter 24(3): 1-6

2019


ISSN/ISBN: 1201-5989
PMID: 31095346
Document Number: 698381
Vitiligo is an acquired, autoimmune disease characterized by depigmented macules and patches on the skin, which occur secondary to melanocyte destruction. Available therapeutic options are broadly divided into medical, surgical and phototherapy, though treatment of vitiligo can be challenging. Early diagnosis and management can maximize treatment efficacy. The purpose of this discussion is to review updates in the management of vitiligo, including existing and emerging therapies.

Document emailed within 1 workday
Secure & encrypted payments